Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Satsuma Pharmaceuticals Inc. sell klostergang

Start price
€4.30
11.09.20
Target price
€2.00
Performance (%)
-19.535%
Price
€3.52
25.09.20

According to klostergang what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Risky balance sheet
ROE lower than 10% per year
No uniques
Growths much slower than the competition
Higher risks for its business
Nicheplayer
Little known brand

Comments by klostergang for this prediction

In the thread Satsuma Pharmaceuticals Inc. diskutieren

Published 11.09.20
Prediction Sell
Perf. (%) -19.535%
Target price 2.000
Change

Sell mit Kursziel 2,0